Source: EURLEX
Language: en
Format: md

|  |  |  |  |
| --- | --- | --- | --- |
| 10.7.2015 | EN | Official Journal of the European Union | C 225/5 |

---

Prior notification of a concentration

(Case M.7681 — Cinven Capital Management/Labco)

Candidate case for simplified procedure

(Text with EEA relevance)

(2015/C 225/04)

|  |  |
| --- | --- |
| 1. | On 29 June 2015 the Commission received a notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004[(1)](#ntr1-C_2015225EN.01000501-E0001) by which Cinven Capital Management (V) General Partner Limited (‘Cinven’, United Kingdom) acquires within the meaning of Article 3(1)(b) of the Merger Regulation control of the whole of the undertaking Labco S.A. (‘Labco’, France) by way of purchase of shares. |

|  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- |
| 2. | The business activities of the undertakings concerned are:   |  |  | | --- | --- | | — | Cinven is a private equity business engaged in the provision of investment management services to a number of investment funds; |  |  |  | | --- | --- | | — | Labco is a pan-European network of laboratories offering medical diagnostic services, including medical biology diagnostics, anatomic pathology diagnostics and medical imaging diagnostics. | |

|  |  |
| --- | --- |
| 3. | On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved. Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under the Council Regulation (EC) No 139/2004[(2)](#ntr2-C_2015225EN.01000501-E0002) it should be noted that this case is a candidate for treatment under the procedure set out in this Notice. |

|  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- |
| 4. | The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.  Observations must reach the Commission not later than 10 days following the date of this publication. Observations can be sent to the Commission by fax (+32 22964301), by email to COMP-MERGER-REGISTRY@ec.europa.eu or by post, under reference number M.7681 — Cinven Capital Management/Labco, to the following address:   |  | | --- | | European Commission | | Directorate-General for Competition | | Merger Registry | | 1049 Bruxelles/Brussel | | BELGIQUE/BELGIË | |

---

[Top](#document1)